Start free trial

BSHeadline Over Filing

A forecast with no evidence

His own founders' letter says potentially, and lists underpromise and overdeliver.

“Cancer, Alzheimer's, heart disease and mental illness will be relics of the past in less than a decade.”

Dario Amodei, Anthropic CEO, in the company's IPO roadshow video, 10 November 2026

19 receipts2 support8 refute9 context

Issue 7015 November 20263 min
A salesman shows a MIRACLES banner while a note on his podium says MAYBE.
AI illustration

The record holds no result that supports the timeline; the founders' letter says AI could potentially cure these diseases.

The twist

In August, Amodei wrote that saying AI will cure cancer is a cliché most people think is deceptive.

4diseases Amodei named in the roadshow video
42 minuteslength of the roadshow video
10 yearsthe timeline Karl Lauterbach calls impossible

There’s more to this story.

Membership opens the full investigation, the strongest counterargument and what to do with what you’ve learned.

30 days free, then A$89 a year. Payment card required. Cancel before the trial ends to avoid the first charge.

Start free trial →
  1. At sign-up: 30 days free. Payment card required. One introductory trial per customer.
  2. Your trial ends 30 days after you start. Unless you cancel before then in Account → Manage subscription, we charge A$89 for the first year. It renews automatically at A$89/yr until cancelled.
  3. You can ask for a full refund within 14 days after any annual payment, renewals included, with no reason needed, by emailing hello@bskiller.com. This voluntary refund does not limit your rights under the Australian Consumer Law.

By starting your trial, you agree to the Terms.

Inferno Tech Pty Ltd t/a BS Killer, ABN 27 647 413 474

Already a member? Sign in

The trick has a name

We call it Headline Over Filing: the document underneath says something else. You'll see it again. Learn to spot it →

Say this in tomorrow's meeting“Amodei's roadshow said four diseases will be gone in under a decade. His own IPO letter says potentially, and in August he called that line deceptive.”

Receipts

  1. Supports businessinsider.com: these will be relics of the past in, I think, less than a decade.
  2. Context businessinsider.com: In a 42-minute IPO roadshow video the company released on Tuesday,
  3. Supports businessinsider.com: "I think if we do this right, we can create an age of miracles," Amodei said in the video.
  4. Context thenextweb.com: potentially curing diseases that have plagued humanity for millennia, including cancer, Alzheimer’s disease, heart disease, rare genetic diseases, and the major infectious diseases
  5. Refutes thenextweb.com: The same letter lists “underpromise and overdeliver” among Anthropic’s guiding principles.
  6. Refutes businessinsider.com: "Curing cancer, Alzheimer's and mental illnesses can definitely benefit from AI. But that is impossible in just 10 years," Karl Lauterbach, Germany's former health minister, said on X.
  7. Refutes thenextweb.com: “Anthropic has done nothing to suggest they themselves will contribute meaningfully to these goals,” Chu said.
  8. Refutes thenextweb.com: “I’ve taken two companies public. These are insane things to say in an IPO pitch,” Elghandour said, according to Business Insider.
  9. Refutes businessinsider.com: saying that AI will cure cancer is more a cliché than it is inspiring, and most people think it is deceptive.
  10. Context businessinsider.com: In an October blog post, the company said it had "begun drug discovery efforts of our own."
  11. Context thenextweb.com: Preparing its daily situation report fell from a full day to under an hour, the founders wrote.
  12. Context thenextweb.com: Its shares are due to start trading on Nasdaq on 19 November.
  13. Refutes martincid.com: the most accurate criticism of AI companies, Anthropic included, is that “we haven’t yet delivered on our big promises to benefit the world,”
  14. Context businessinsider.com: Karl Lauterbach, Germany's former health minister, said on X.
  15. Refutes businessinsider.com: Melinda B. Chu, an AI medical researcher with an MD from Saint Louis University, said Amodei made those predictions just to stoke hype for the company's IPO.
  16. Refutes businessinsider.com: Rami Elghandour, a biotech executive, said Amodei's prediction reeks of desperation.
  17. Context thenextweb.com: The World Health Organization’s Regional Office for Africa used Claude during the 2026 Ebola outbreak in the Democratic Republic of the Congo.
  18. Context businessinsider.com: In an August X post, Amodei said that the best way to win over AI skeptics is for AI companies to
  19. Context martincid.com: The sharpest rebuttal comes from Amodei himself. In an X post in August, he wrote that

Open the Receipts Pack → What each source proves, every figure traced, and what would change our verdict.

Checked by AI at the BS Killer desk · ruled 15 Nov 2026 · How we check →

Get tomorrow's check in your inbox.

One AI claim a night, checked against independent sources, receipts attached. Free.

Free email updates. Unsubscribe any time.

This story is a stable, citable object. If you can falsify a verdict, tell us. Corrections are loud here.